arrow
P

Petros Kountouris

the cyprus institute of neurology and genetics
H指数:14
被引数:749

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children

在大多数镰状细胞病患者中检测不到羟基脲水平,尤其是在幼儿中

2026-07-030
OAAI
Mapping Current and Emerging Laboratory Techniques for Haemoglobinopathy Carrier Detection and Prevention: A Narrative Review from the HELIOS Action

绘制血红蛋白病携带者检测和预防的当前及新兴实验室技术图谱:一份来自HELIOS行动的叙事性综述

2026-04-280
OAAI
Modifying quality and equity of care: emerging roles of genetic disease modifiers in β-hemoglobinopathies

改善护理的质量与公平性:β-血红蛋白病中遗传修饰因子的新兴作用

2026-01-010
OA
HELIOS Action: Advancing research, education, and equity in hemoglobinopathies across Europe and beyond

HELIOS行动计划:推动欧洲及全球范围的血红蛋白病研究、教育和公平。

2025-12-010
OAAI
Metabolomics in sickle cell disease: Current knowledge and gaps – A scoping review

镰状细胞病中的代谢组学:现有知识及空白——一篇范围综述

2025-09-060
PREAI
Non-Invasive Determination of the Paternal Inheritance in Pregnancies at Risk for β-Thalassaemia by Analyzing Cell-Free Fetal DNA Using Targeted Next-Generation Sequencing

通过靶向下一代测序分析游离胎儿DNA,对β-地中海贫血高风险妊娠进行父系遗传的非侵入性确定

2025-01-100
OA
Global Globin Network and adopting genomic variant database requirements for thalassemia
2024-09-040
OAAI
Sickle cell disease landscape and challenges in the EU the ERN-EuroBloodNet perspective

欧盟的镰状细胞病景观和挑战ern-eurobloodnet观点

2023-08-0111
PRE
Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet
2023-03-013
OAAI
Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries
2022-03-3111
OA
Adapting the ACMG/AMP variant classification framework: A perspective from the ClinGen Hemoglobinopathy Variant Curation Expert Panel

适应ACMG/AMP变体分类框架: ClinGen血红蛋白病变体治疗专家小组的观点

2021-09-2425
OAAI
The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies
2021-08-3024
OAAI